1-[[3-methoxy-4-[(6-methoxy-3-pyridinyl)methoxy]phenyl]methyl]-5-(1-piperidin-4-ylpyrazol-4-yl)benzimidazole
C30H32N6O3 — CID 118009777
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[3-methoxy-4-[(6-methoxy-3-pyridinyl)methoxy]phenyl]methyl]-5-(1-piperidin-4-ylpyrazol-4-yl)benzimidazole
1-[[3-methoxy-4-[(6-methoxy-3-pyridinyl)methoxy]phenyl]methyl]-5-(1-piperidin-4-ylpyrazol-4-yl)benzimidazole (PubChem CID 118009777) has the molecular formula C30H32N6O3 and a molecular weight of 524.63 g/mol. Its IUPAC name is 1-[[3-methoxy-4-[(6-methoxy-3-pyridinyl)methoxy]phenyl]methyl]-5-(1-piperidin-4-ylpyrazol-4-yl)benzimidazole.
Molecular Properties
| Compound Name | 1-[[3-methoxy-4-[(6-methoxy-3-pyridinyl)methoxy]phenyl]methyl]-5-(1-piperidin-4-ylpyrazol-4-yl)benzimidazole |
|---|---|
| PubChem CID | 118009777 |
| Molecular Formula | C30H32N6O3 |
| Molecular Weight | 524.63 g/mol |
| Exact Mass | 524.25 |
| IUPAC Name | 1-[[3-methoxy-4-[(6-methoxy-3-pyridinyl)methoxy]phenyl]methyl]-5-(1-piperidin-4-ylpyrazol-4-yl)benzimidazole |
| SMILES | COc1ccc(COc2ccc(Cn3cnc4cc(-c5cnn(C6CCNCC6)c5)ccc43)cc2OC)cn1 |
| InChI | InChI=1S/C30H32N6O3/c1-37-29-13-21(3-7-28(29)39-19-22-4-8-30(38-2)32-15-22)17-35-20-33-26-14-23(5-6-27(26)35)24-16-34-36(18-24)25-9-11-31-12-10-25/h3-8,13-16,18,20,25,31H,9-12,17,19H2,1-2H3 |
| InChIKey | OZFHIGAKHHLPEF-UHFFFAOYSA-N |
| XLogP | 4.86 |
| TPSA | 88.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 524.63 |
| LogP ≤ 5 | 4.86 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118009777 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.